¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Quiet Time Oral"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
  • phonation time
    ¹ß¼ºÁö¼Ó½Ã°£
  • polymerizing time
    ÁßÇսð£
  • potential doubling time
    ÀáÀç¹è°¡½Ã°£
  • prothrombin time
    ÇÁ·ÎÆ®·Òºó½Ã°£
  • partial thromboplastin time
    ºÎºÐÆ®·Òº¸ÇÃ¶ó½ºÆ¾½Ã°£
  • peak concentration time
    ÃÖ°í³óµµ½Ã°£
  • perception time
    Áö°¢½Ã°£
  • person-time incidence rate
    »ç¶÷±â°£¹ß»ý·ü
  • reaction time
    ¹ÝÀÀ½Ã°£
  • reaction time crossover
    ¹ÝÀÀ½Ã°£±³Â÷
  • real time acquisition
    ½Ç½Ã°£È¹µæ
  • real time display
    ½Ç½Ã°£Ç¥½Ã
  • real time imaging
    ½Ç½Ã°£¿µ»ó
  • real time PCR
    ½Ç½Ã°£ÁßÇÕÈ¿¼Ò¿¬¼â¹ÝÀÀ
  • real time study
    ½Ç½Ã°£°Ë»ç
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
  • real time imaging
    ½Ç½Ã°£¿µ»ó
  • tension time index
    Àå·Â½Ã°£°è¼ö
  • time interval
    ½Ã°£°£°Ý
  • latent time
    Àẹ½Ã°£
  • lead time
    Á¶±â¹ß°ß±â°£
  • maximum phonation time
    ÃÖÀå¹ß¼ºÁö¼Ó½Ã°£
  • mean survival time
    Æò±Õ»ýÁ¸½Ã°£
  • mean tidal time
    Æò±Õ¼øÈ¯½Ã°£
  • time dependent relative risk model
    ½Ã°£ÀÇÁ¸»ó´ëÀ§Çè¸ðµ¨
  • partial thromboplastin time
    ºÎºÐÆ®·Òº¸ÇÃ¶ó½ºÆ¾½Ã°£
  • peak concentration time
    ÃÖ°í³óµµ½Ã°£
  • perception time
    Áö°¢½Ã°£, ÀνĽð£
  • person-time incidence rate
    »ç¶÷±â°£¹ß»ý·ü
  • phonation time
    ¹ß¼ºÁö¼Ó½Ã°£
  • polymerizing time
    ±»´Â½Ã°£, ÁßÇսð£
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
  • oral habit
    ±¸º®(Ï¢Ûþ).
  • oral hairy leukoplakia
    ÀԾȸð¾ç ¹éÆÇÁõ
  • oral hairyleukoplakia
  • oral health =o. hygiene
    ±¸°­À§»ý(Ϣ˷ êÛßæ).
  • oral health =o. hygiene
    ±¸°­À§»ý(˴˧ ËôË×).
  • oral health [=o. hygiene]
    ±¸°­À§»ý
  • oral hemorrhage
    ±¸°­ÃâÇ÷
  • oral hemorrhage
    ±¸°­ÃâÇ÷(Ϣ˷õóúì).
  • oral herpes simplex virus
    ±¸°­ ´Ü¼øÆ÷Áø¹ÙÀÌ·¯½º
  • oral hygiene
    ±¸°­À§»ý(˴˧ËôË×).
  • oral hygiene in pregnancy
    ÀӽŽñ¸°­À§»ý(ìôãããÁϢ˷êÛßæ).
  • oral hygiene index
    ±¸°­À§»ýÁö¼ö(¡­ò¦â¦).
  • oral hygiene index
    ±¸°­À§»ýÁö¼ö(ÊṲ̀Ëà).
  • oral hypoglycemic agents
    °æ±¸´ç´¢º´¾àÁ¦(ÌèÏ¢ÓØèñÜ»å·ð¥).
  • oral hypoglycemic agents
    °æ±¸´ç´¢º´¾àÁ¦(ÌèÏ¢ÓØèñÜ»å·ð¥).
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 7
SRT sedimentation rate test; simple reaction time; sinus node recovery time; sitting root test; speech r...
tcTOFA time constrained time-of-flight absorbance
TD the time required to double the number of cells in a given population; thermal death time
TDT terminal deoxynucleotidyltransferase; thermal death time; tone decay test; tumor doubling time
TE exhalation time; expiratory phase time
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 7
OCP Oral contraceptive pill
OCS Oral contraceptive steroids
OCA Oral contraceptives agents
OGTT Oral glucose tolerance
OGTT Oral glucose tolerance testing
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • oral mucosa change
    ±¸°­ Á¡¸· º¯È­
  • oral neurosis
    ±¸°­ ½Å°æÁõ
  • oral orthopedics
    ±¸°­ Á¤Çü¿Ü°úÇÐ
    Á¤»óÀûÀ̰ųª ºñÁ¤»óÀûÀÎ ¾Ç°ñÀÇ À§Ä¡ °ü°è, Áø´Ü, Ä¡·á, ¿¹¹æÀû °í·Á »çÇ×À» Æ÷ÇÔÇÏ¿© ±¸°­ ±¸Á¶¹°¿¡ ´ëÇÑ ±× È¿°ú¸¦ ºÐ¼®ÇÏ´Â °Í.
  • oral parafunctional habit
    ±¸°­ ¾Ç½À°ü
  • oral personality
    ±¸°­±â ÀΰÝ, ±¸¾Ö¼º ÀΰÝ
  • oral phimosis
    ¼Ò±¸, ¼Ò±¸Áõ
  • oral poliovirus vaccine
    ¼Ò¾Æ¸¶ºñ °æ±¸ ¹é½Å, Æú¸®¿À °æ±¸ ¹é½Å
  • oral region
    ±¸°­ ¿µ¿ª, ÀÔ ºÎÀ§, ±¸ºÎ
  • oral respiration
    ÀÔ È£Èí, ±¸°­ È£Èí
  • oral screen
    ±¸³» Â÷ÆóÆÇ, ±¸°­ Ç¥ÁظÁ
    ÇϾǰñ ¿îµ¿¿¡ °ü¿©ÇÏ´Â ±ÙÀ°À» ¿îµ¿½ÃŰ´Â ÀåÄ¡. ¼Õ°¡¶ô »¡±â, ÀÔ¼ú ±ú¹°±â, Çô ³»¹Ð±â, ±¸È£Èí µî¿¡ Àû¿ëÇÑ´Ù.
  • oral sepsis
    ±¸°­ ºÎÆÐÁõ
  • oral skeletal muscle relaxant
    ±¸°­ °ñ°Ý±Ù ÀÌ¿ÏÁ¦
  • oral stimulation
    ±¸°­³» ÀÚ±Ø
  • oral submucous
    ±¸°­ Á¡¸·ÇÏ
  • oral surgery
    ±¸°­¿Ü°ú, ±¸°­¿Ü°úÇÐ
    ÀÌ, ÅÎ, ±¸°­ µîÀÇ ¿Ü°úÀû Ä¡·á¸¦ Àü¹®À¸·Î ÇÏ´Â Áø·á°ú¸ñ. Ä¡·áÀÇ ´ë»óÀÌ µÇ´Â Áß¿äÇÑ º´Àº ¿Ü°úÀû óġ¸¦ ÇÊ¿ä·Î ÇÏ´Â Ä¡¾Æ Áúȯ, ÀÔ¼ú, ÅÎ, ±¸°³ µîÀÇ ¿­±âÇü, ¼±ÃµÀûÀ̰ųª ÈÄõÀûÀÎ ÅÎ ºÎºÐÀÇ º¯ÇüÁõ, ¾Ç°ñ °ñÀý µîÀÇ ¾Ç¾È¸é ¿Ü»ó, ¿°Áõ¼º Á¦Áúȯ, ³¶Æ÷¼º Áúȯ, ¾ç¼º ¶Ç´Â ¾Ç¼ºÀÇ Á¦Á¾Á¾¾ç, ¾Ç°üÀý Áúȯ, Ÿ¾×¼± Áúȯ µîÀÌ´Ù. ÀÌ ¹Û¿¡ ±¸°­ ¿µ¿ª¿¡ ÁÖ¿ä º´º¯À̳ª Áõ¼¼°¡ ³ªÅ¸³ª´Â ³»°úÀû ¶Ç´Â ÇǺÎÀû Áúȯµµ Áø·áµÈ´Ù. ¶ÇÇÑ Â÷ÀûÀ̱ä ÇÏÁö¸¸ ÇüÅÂÀûÀÎ ±¸À½ Àå¾Ö, ¹ß¾ð Àå¾Ö´Â À̺ñÀÎÈİú¿ÍÀÇ Çùµ¿ ´ë»óÀ̱⵵ ÇÏ´Ù.
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 7
P-H conduction time See: atrioventricular conduction.
(05 Mar 2000)
running time The time during which an activity (e.g., chromatography development) occurs.
(05 Mar 2000)
Russell's viper venom clotting time A clotting time determination performed on citrated platelet-poor plasma using Russell's viper venom as an activating agent. This allows activation of factor X directly without the need for other coagulation factors and is used to confirm factor X defects.
See: Stypven time test.
(05 Mar 2000)
circulation time The time taken for the blood to pass through a given circuit of the vascular system, e.g., the pulmonary or systemic circulation, from one arm to another, from arm to tongue, or from arm to lung; it is measured by the injection into an arm vein of a substance, such as sodium dehydrocholate, ether, fluorescein, histamine, or a radium salt, which can be detected when it arrives at another point in the vascular system.
(05 Mar 2000)
clot retraction time The time required for a blood clot to separate from the tube wall and express serum, usually completed in 18 to 24 hours, but retarded or absent in persons with thrombocytopenic purpura.
(05 Mar 2000)
clotting time The time required for blood to coagulate; prolonged in haemophilia and in the presence of obstructive jaundice, some anaemias and leukaemias, and some of the infectious diseases.
Synonym: clotting time.
(05 Mar 2000)
coagulation time The time required for blood to coagulate; prolonged in haemophilia and in the presence of obstructive jaundice, some anaemias and leukaemias, and some of the infectious diseases.
Synonym: clotting time.
(05 Mar 2000)
collision time <radiobiology> Typical time which passes between two consecutive collision events for a given particle. Inverse of the collision frequency, equal to the mean free path divided by the particle's velocity. In plasmas, the (Coulomb) collision time decreases with increasing density, and increases with increasing temperature.
(09 Oct 1997)
whole blood coagulation time Measurement of the time required by whole blood to produce a visible clot. Factors that could influence the test are all but III, vii, and xiii. Activation may be by contact with the glass tube or exposure to diatomaceous earth. Delay of onset of coagulation may be achieved by use of nonwettable plastic or silicone-coated glass tubes. It is used for monitoring heparin therapy and as a bedside screening test for deficiencies in the intrinsic coagulation pathway. "activated coagulation time" is sometimes referred to as act.
(12 Dec 1998)
confinement time <radiobiology> There are several types. The general definition is tau = [total]/[loss per unit time], hence Tau_E = [total energy]/[energy loss per unit time]. Tau_[E, N,.] is the amount of time the plasma is contained (for example, by magnetic fields) before its [energy (E), particles (N or P)] leak / dissipate away. The different types are, in general, similar but not equal. (N.B., Tau_E is NOT electron confinement time!)
(09 Oct 1997)
continuous time model <epidemiology> A model in which the system changes continuously over time. Derivatives (e.g. DY/dt ) are the mathematical formalism for describing such continuous change. The differential equation which embodies a model provides the values of these derivatives at any particular time point; calculus or a computer can then be used to move the state of the model forwards in time.
Continuous models have the advantage over discrete time models in that they are more amenable to algebraic manipulation, although they are slightly harder to implement on a computer.
The same as a differential equation model.
(05 Dec 1998)
half-time The time, in a first-order chemical (or enzymic) reaction, for half of the substance (substrate) to be converted or to disappear.
Compare: half-life.
(05 Mar 2000)
prothrombin time Measurement of clotting time of plasma recalcified in the presence of excess tissue thromboplastin. Factors measured are fibrinogen, prothrombin, and factors v, vii, and x. It is used for monitoring anticoagulant therapy with coumarins.
(12 Dec 1998)
sensation time The minimal time a visual image must be exposed in order to be perceived.
(05 Mar 2000)
H-R conduction time Conduction of the cardiac impulse through the ventricular myocardium, represented by the QRS complex in the electrocardiogram. H-R conduction time is from the onset of the first high frequency component of the His bundle electrogram to the onset of the QRS complex of the surface electrocardiogram (normally 43 &plusmn; 12 msec); H-V conduction time is from the onset of the first high frequency component of the His bundle electrogram to the onset of the ventricular electrogram (normally approximates the H-R interval but may be a little shorter).
Synonym: ventricular conduction.
(05 Mar 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
  • real-time
    ½Ç½Ã°£ÀÇ;(±â·Ï.¹æ¼ÛµîÀÌ)Áï½ÃÀÇ;µ¿½ÃÀÇ
  • real-time system
    ½Ç½Ã°£(Áï½Ãó¸®)½Ã½ºÅÛ(´Ü¸»¿¡¼­ º¸³»¿Â µ¥ÀÌÅ͸¦ Áï½Ã ÄÄÇ»ÅÍ¿¡ ó¸®ÇÏ¿© ´Ü¸»·Î µÇµ¹¸®´Â ½Ã½ºÅÛ)
  • released time
    ±³¿Ü Á¾±³ ±³À° µîÀ» À§ÇÑ ÀÚÀ¯ ½Ã°£
  • response time
    ÀÀ´ä ½Ã°£
  • reverberating time
    ÀÜÇâ½Ã°£
  • short time
    Á¶¾÷ ´ÜÃà
  • small time
    (ÇÏ·ç¿¡ ¸î¹ø¾¿ »ó¿¬ÇÏ´Â)½Î±¸·Á ¿¬¿¹(¿¬±Ø)
  • standard time
    Ç¥ÁؽÃ
  • straight time
    ±ÔÁ¤ ³ëµ¿½Ã°£
  • time
    ¶§ÀÇ;½ÃÇÑÀÇ;ÈĺÒÀÇ
  • time
    ½Ã°£;¶§;¼¼¿ù;±â°£;½Ã°¢;½Ã;»ý¾Ö;½Ã±â;(º¹¹«)¿¬ÇÑ;±Ù¹«½Ã°£;°æÇè;½Ã¼¼;¿©°¡;¹ø;¹ÚÀÚ;at the same ~ µ¿½Ã¿¡. at ~s ¶§¶§·Î;behind the ~s ±¸½ÄÀÇ;for a ~ ÇѶ§;Àá½Ã;for the ~ being ´çºÐ°£
  • time
    ¹ÚÀÚ¸¦ ¸ÂÃß´Ù;Àå´ÜÀÌ ¸Â´Ù(with)
  • time
    ½Ã°£À» Àç´Ù;¹ÚÀÚ¸¦ ¸ÂÃß´Ù;ÁÁÀº ½Ã±â¿¡ ¸ÂÃß´Ù;...ÀÇ ½Ã°£À» Á¤ÇÏ´Ù
  • time base
    ½Ã°£Ãà
  • time belt
    =time zone
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 7
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 7
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 7
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 7
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 7
ÅëÇÕ°Ë»ö ¿Ï·á